Quick Answer
iBio, Inc. reported Common Stock Shares Outstanding of 19.35 million shares for the year ending 2025.
- iBio, Inc. showed an increase of +124.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from iBio, Inc.'s annual report (Form 10-K), filed with the SEC on September 5, 2025.
- XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2012 to 2025), iBio, Inc.'s Common Stock Shares Outstanding has declined by 59.5%.
- Historical annual values: Fiscal year 2025: 19.35 million shares | Fiscal year 2024: 8.62 million shares | Fiscal year 2023: 1.02 million shares | Fiscal year 2022: 8.73 million shares | Fiscal year 2021: 8.71 million shares | Fiscal year 2020: 140.07 million shares | Fiscal year 2019: 20.15 million shares | Fiscal year 2018: 16.04 million shares | Fiscal year 2017: 8.91 million shares | Fiscal year 2017: 89.12 million shares | Fiscal year 2016: 89.11 million shares | Fiscal year 2015: 77.21 million shares | Fiscal year 2014: 65.64 million shares | Fiscal year 2013: 56.69 million shares | Fiscal year 2012: 47.77 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: